Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-09-12 5:51:12 am | Adaptimmune: Spinning Sarcoma Into Gold | SeekingAlpha |
| 2023-09-11 5:0:0 am | Dr. Karen Chagin Joins Adaptimmune as Senior Vice President of Early-Stage Development | Newsfile |
| 2023-08-09 4:29:0 am | Adaptimmune Reports Second Quarter Financial Results and Business Update | Newsfile |
| 2023-08-03 10:24:0 am | Adaptimmune to Report Q2 2023 Financial and Business Updates on Wednesday, August 9, 2023 | Newsfile |
| 2023-07-28 9:30:0 am | Adaptimmune (ADAP) to Report Q2 Earnings: What's in the Cards? | Zacks |
| 2023-07-20 4:28:58 am | Investors in Adaptimmune Therapeutics (NASDAQ:ADAP) from five years ago are still down 90%, even after 12% gain this past week | Simply Wall St. |
| 2023-07-16 5:18:0 pm | Arcturus Therapeutics (ARCT) Surges 15.0%: Is This an Indication of Further Gains? | Zacks |
| 2023-06-29 6:18:0 am | Reata's (RETA) Skyclarys PAS Gets FDA Nod, Stock Rises 7% | Zacks |
| 2023-06-26 8:23:0 am | AbbVie (ABBV) Gets CHMP Positive Opinion for Atogepant Approval | Zacks |
Please consider a small donation if you think this website provides you with relevant information